July 9 (Reuters) - Mylan NV:
* MYLAN AND FUJIFILM KYOWA KIRIN BIOLOGICS ANNOUNCE U.S. FDA APPROVAL OF HULIO® (ADALIMUMAB-FKJP)
* MYLAN AND FUJIFILM KYOWA KIRIN BIOLOGICS ANNOUNCE U.S. FDA APPROVAL OF HULIO® (ADALIMUMAB-FKJP)
* MYLAN NV - MYLAN WILL BE ABLE TO LAUNCH HULIO IN U.S. DURING JULY 2023.
* MYLAN NV - WILL BE ABLE TO LAUNCH HULIO IN U.S. DURING JULY 2023 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.